Back to results
CompletedPhase 1

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

NCT00675090

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Randwick, New South Wales, Australia

+7 additional locations

View on ClinicalTrials.gov
Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease — TrialFind